Covis Pharmaceuticals (688136.SH) plans to launch a restricted stock incentive plan for 2026.

China Fortune Financial News APP News, Kexing Pharmaceuticals (688136.SH) disclosed the 2026 restricted stock incentive plan (draft), the incentive plan plans to grant a total of 4.943 million restricted stocks to incentive recipients, accounting for 2.46% of the total share capital of the company on the announcement date of the incentive plan draft. The grant price of the restricted stocks is 14.35 yuan per share.